Eversept Partners, LP Century Therapeutics, Inc. Transaction History

Eversept Partners, LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$20.8 - $31.93 $2.1 Million - $3.22 Million	-100,901 Closed	0 $0
Q2 2021 Nov 08, 2023	BUY	$22.45 - $29.34 $2.27 Million - $2.96 Million	100,901 New	100,901 $2.96 Million
Q2 2021 Aug 16, 2021	BUY	$22.45 - $29.34 $2.27 Million - $2.96 Million	100,901 New	100,901 $2.96 Million

36.9M

8.7K

10.2K

Ticker IPSC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,881,800
Market Cap $71.2M
Description
Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 fo...

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

Stay updated on Eversept Partners, LP with notifications on news.